AUSTIN, Texas, March 26, 2015 (GLOBE NEWSWIRE) -- SmallCapVoice.com, Inc. (SCV) announced today that a new audio interview with BioCorRx, Inc. (OTC QB:BICX), developer of the Start Fresh Program, is now available. The interview can be heard at http://smallcapvoice.com/blog/3-24-15-smallcapvoice-interview-with-biocorrx-inc-bicx.
COO and interim CEO Brady Granier of BioCorRx, Inc., called in to SmallCapVoice.com, Inc. to go over the recent news for the Company. In the interview Mr. Granier discusses the recently announced execution of a definitive agreement with Myriad Medical Marketing (MMM), the reinstatement of the letter of understanding (LOU) to acquire Trinity Rx Solutions and all of its formulas, as well as new clinic openings so far in 2015.
In the interview Mr. Granier stated, "Things (with Myriad Medical Marketing (MMM)) are progressing rather quickly. We moved from the LOI to the definitive agreement in about a month. They are very eager to get going on this pilot for this new model. It has all fallen into place rather nicely. With the definitive agreement now in place all of our interests are aligned."
SmallCapVoice.com is a recognized corporate investor relations firm, with clients nationwide, known for its ability to help emerging growth companies build a following among retail and institutional investors. SmallCapVoice.com utilizes its stock newsletter to feature its daily stock picks, audio interviews, as well as its clients' financial news releases. SmallCapVoice.com also offers individual investors all the tools they need to make informed decisions about the stocks they are interested in. Tools like stock charts, stock alerts, and Company Information Sheets can assist with investing in stocks that are traded on the OTC BB and Pink Sheets. To learn more about SmallCapVoice.com and their services, please visit http://www.smallcapvoice.com/services.html or sign up for our FREE newsletter here http://www.smallcapvoice.com/newsletter.html.
Visit BioCorRx, Inc.'s investor relations website www.BICXcorp.com to receive the most up to date company information.
About BioCorRx, Inc.
BioCorRx, Inc. (R) (BICX) is an addiction treatment and rehabilitation company offering a unique approach to the treatment of substance abuse addiction. The Start Fresh Program(R) consists of two components. The first component of the program consists of an outpatient implant procedure performed by a licensed physician. The implant delivers therapeutic levels of the drug Naltrexone, an opioid antagonist that significantly reduces physical cravings for alcohol and opioids, into the body. The second component of the program developed by BioCorRx, Inc. is a one on one coaching program specifically tailored for the treatment of alcoholism and other substance abuse addictions. Clinic reports show that the treatment program can be successful for individuals who complete the program. For more information on BICX, visit www.BioCorRx.com
2014 was a pivotal year for BioCorRx, Inc. Clinics using the Start Fresh Program collectively saw a 402% increase in patients treated from 2013 to 2014. Over the course of 2015, the company is continuing the process of developing more new territories to continue expansion.
Number of clinics at the end of each quarter
-Q1, 2014 -- 5 clinics offering the Start Fresh Program
-Q2, 2014 -- 6 clinics offering the Start Fresh Program
-Q3, 2014 -- 6 clinics offering the Start Fresh Program
-Q4, 2014 -- 10 clinics offering the Start Fresh Program
-Q1, 2015 to date - 13 clinics offering the Start Fresh Program
Safe Harbor Statement
The information in this release includes forward-looking statements. These forward-looking statements generally are identified by the words "believe," "project," "estimate," "become," "plan," "will," and similar expressions. These forward-looking statements involve known and unknown risks as well as uncertainties. Although the Company believes that its expectations are based on reasonable assumptions, the actual results that the Company may achieve may differ materially from any forward-looking statements, which reflect the opinions of the management of the Company only as of the date hereof.
CONTACT: Investor Relations SmallCapVoice.com, Inc. 512-267-2430 firstname.lastname@example.org